Patents Assigned to ESM Technologies, LLC
  • Patent number: 11020437
    Abstract: The present invention relates to the use of eggshell membrane compositions to activate levels of nuclear factor kappa-light-chain-enhancer of activated B cells (“NF-?B”) in the gut of a host in need thereof and methods of treating conditions related to NF-?B dysregulation.
    Type: Grant
    Filed: June 6, 2019
    Date of Patent: June 1, 2021
    Assignee: ESM TECHNOLOGIES, LLC
    Inventor: Kevin J. Ruff
  • Patent number: 10328104
    Abstract: The present invention relates to the use of eggshell membrane compositions to activate levels of nuclear factor kappa-light-chain-enhancer of activated B cells (“NF-?B”) in the gut of a host in need thereof and methods of treating conditions related to NF-KB dysregulation. The herein invention provides a method for activating NF-?B in the gut of a host in need thereof. The method comprises orally administering an effective amount of a composition consisting essentially of eggshell membrane, and/or eggshell membrane isolates and/or eggshell membrane hydrolysates for activation of NF-?B to the host.
    Type: Grant
    Filed: October 8, 2015
    Date of Patent: June 25, 2019
    Assignee: ESM TECHNOLOGIES, LLC
    Inventor: Kevin J. Ruff
  • Patent number: 9983214
    Abstract: The invention provides a method for determining the efficacy of compositions used to treat articular joint conditions in mammals. The method includes measuring the change in levels of one or more cartilage degradation biomarkers in a mammal from before exercise and after exercise, then administering a composition used to treat articular joint conditions to the mammal, and measuring the change in levels of one or more cartilage degradation biomarkers in the mammal from before exercise and after exercise.
    Type: Grant
    Filed: April 15, 2016
    Date of Patent: May 29, 2018
    Assignee: ESM Technologies, LLC
    Inventor: Kevin J. Ruff
  • Publication number: 20130337080
    Abstract: The present invention provides a dietary supplement that promote the growth, repair, and maintenance of mammalian bone and joint connective tissue. In particular, the dietary supplement comprises a combination of at least one metal chelate and at least one chondroprotective agent.
    Type: Application
    Filed: January 9, 2012
    Publication date: December 19, 2013
    Applicant: ESM Technologies, LLC
    Inventors: Karen Wedekind, Kevin Ruff
  • Patent number: 8580315
    Abstract: The present invention relates to anti-inflammatory activity of eggshell membrane, processed eggshell membrane preparations and eggshell membrane isolates. The invention is directed to eggshell membrane compositions exhibiting anti-inflammatory activity as measured by effects on down-regulating pro-inflammatory plasma antigens in mammals that had orally ingested such compositions. This information supports the potential benefits from administration of naturally occurring material found in eggshell membrane, processed eggshell membrane, eggshell membrane isolates and combinations to reduce pain and inflammation associated with arthritis and other inflammatory conditions.
    Type: Grant
    Filed: March 7, 2007
    Date of Patent: November 12, 2013
    Assignee: ESM Technologies, LLC
    Inventors: Dale Paul DeVore, Frank Daniel Long